Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CSLCSLLY +0.92%76 5-Year Dividend Growth Rate is 9.80% as of Dec. 2025. GuruFocus rates CSLLY with a GF Score™ of 76/100 and a GF Value™ of $42.69 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 56 Biotechnology companies, CSL ranks better than 50% on this metric.
During the past 12 months, CSL's average Dividends Per Share Growth Rate was -34.30% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 11.60% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 9.80% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 11.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of CSL was 42.20% per year. The lowest was 6.60% per year. And the median was 15.90% per year.
During the past 13 years, the highest Dividend Payout Ratio of CSL was 0.51. The lowest was 0.39. And the median was 0.45.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
CSL Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
USD 0.319217
2026-03-11
2026-03-11
2026-04-16
Cash Dividend
semi-annually
USD:USD 1.000000
USD 0.405000
2025-09-10
2025-09-10
2025-10-10
Cash Dividend
semi-annually
USD:USD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
CSL's Dividend Yield (%) for Today is calculated as
Current Share Price is $23.515.
CSL's Dividends per Share for the trailing twelve months (TTM) ended in Today is $0.724217.
During the past 13 years, the highest Dividend Yield of CSL was 4.46%. The lowest was 0.76%. And the median was 1.11%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CSL 5-Year Dividend Growth Rate Related Terms
CSLLY vs VRTX, REGN, RVMD: 5-Year Dividend Growth Rate Comparison
For the Biotechnology subindustry, CSL's 5-Year Dividend Growth Rate, along with its competitors' market caps and 5-Year Dividend Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CSL 5-Year Dividend Growth Rate vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, CSL's 5-Year Dividend Growth Rate distribution charts can be found below:
* The bar in red indicates where CSL's 5-Year Dividend Growth Rate falls into.
This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with least square regression.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 5-Year Dividend Growth Rate of 9.80% mean?
CSL (CSLLY) has a 5-Year Dividend Growth Rate of 9.80% as of Dec. 2025. 5-Year Dividend Growth Rate is the company's five-year average growth of dividend payout. View historical data on CSL and its competitors. According to the industry distribution chart, CSL ranks #28 out of 56 companies in the Biotechnology industry, placing it in the top 50%.
Is CSL's 5-Year Dividend Growth Rate too high?
CSL's current 5-Year Dividend Growth Rate is 9.80%. The Biotechnology industry median 5-Year Dividend Growth Rate is 9.70. CSL's value of 9.80% is 1% above this industry median. Based on the distribution chart, CSL ranks #28 out of 56 companies in the Biotechnology industry, which is above the industry midpoint. Overall, CSL has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CSL's 5-Year Dividend Growth Rate compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, CSL ranks #28 out of 56 companies for 5-Year Dividend Growth Rate. This puts CSL in the upper half of its industry. The industry median 5-Year Dividend Growth Rate is 9.70. CSL's value of 9.80% is 1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Dividend Growth Rate for a Biotechnology company?
The median 5-Year Dividend Growth Rate among Biotechnology companies is 9.70, based on 56 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Dividend Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Dividend Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CSL's current 5-Year Dividend Growth Rate of 9.80% is 1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Dividend Growth Rate mean?
A high 5-Year Dividend Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year Dividend Growth Rate is the company's five-year average growth of dividend payout. View historical data on CSL and its competitors. For the Biotechnology industry, the median 5-Year Dividend Growth Rate is 9.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CSL's current 5-Year Dividend Growth Rate is 9.80%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CSL stock overvalued right now?
Based on GuruFocus' analysis, CSL (CSLLY) is currently considered Significantly Undervalued. The stock's GF Value™ is $42.69, compared to a current price of $23.52 — trading 44.9% below its estimated fair value. The current 5-Year Dividend Growth Rate is 9.80% and 1% above the Biotechnology industry median of 9.70. CSL's overall GF Score™ is 76/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Dividend Growth Rate calculated?
5-Year Dividend Growth Rate is calculated from a company's financial statements. For CSL (CSLLY), the current 5-Year Dividend Growth Rate is 9.80% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CSL (CSLLY) Overvalued in 2026?
Based on GuruFocus' analysis, CSL stock appears to be undervalued.
The current stock price of $23.52 is trading 44.9% below its estimated GF Value™ of $42.69.
GuruFocus considers CSL to be Significantly Undervalued.
Key valuation signals for CSLLY:
5-Year Dividend Growth Rate: 9.80%
GF Value™: $42.69 vs. price of $23.52 (44.9% below fair value)
Industry Position: 1% above the Biotechnology median (#28 of 56)
No single metric tells the full story. See the CSLLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CSL is one of the largest global biotech companies and has three main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders, and neurological indications. CSL Seqirus is the world's second-largest influenza vaccination business and was acquired in fiscal 2016. CSL Vifor is an iron deficiency and nephrology business and was acquired in fiscal 2023. CSL has a strong R&D track record, and the product portfolio and pipeline include nonplasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.
76GF Score
Get the complete analysis for CSLLY
5-Year Dividend Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSLLY has been successfully added to your 
